• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ENDOLOGIX AFX; PROXIMAL EXTENSION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ENDOLOGIX AFX; PROXIMAL EXTENSION Back to Search Results
Device Problems Material Puncture/Hole (1504); Material Separation (1562); Insufficient Information (3190)
Patient Problem Failure of Implant (1924)
Event Date 11/03/2021
Event Type  Injury  
Manufacturer Narrative
The devices involved in this event will not be returned for evaluation and remain implanted in the patient.Patient medical records and imaging studies will be requested for further evaluation by a clinical specialist.If additional information pertinent to the incident is obtained, a follow-up report will be submitted.Device iteration is unknown.Devices remain implanted.
 
Event Description
The patient was initially treated for an abdominal aortic aneurysm (aaa) with an unknown stent system on an unknown date.The physician elected to implant an afx2 bifurcated stent graft and afx vela suprarenal proximal extension on (b)(6) 2021 to treat an unknown device failure.No additional information is currently available regarding this initial report.As the exact date of incident is unknown, the best estimate was used, which is the manufacturer awareness date to this event.
 
Event Description
The patient was initially treated for an abdominal aortic aneurysm (aaa) with an unknown stent system on an unknown date.The physician elected to implant an afx2 bifurcated stent graft and afx vela suprarenal proximal extension on (b)(6) 2021 to treat an unknown device failure.No additional information is currently available regarding this initial report.As the exact date of event is unknown, the best estimate was used, which is the awareness date to this event.Additional information received indicating that a type iiib endoleak of the proximal extension was present at the time of the reported event.In addition, the patient was reportedly also relined with gore (non-endologix) devices during the secondary endovascular procedure in october 2021.Clinical assessment additionally confirmed crown separation occurred that was not included in the event as reported.
 
Manufacturer Narrative
The reported adverse event/incident was investigated in alignment with endologix operating procedures and work instructions.Where possible, it is endologix practice to make at least three good faith efforts to retrieve a reported adverse event/incident related device as well as medical records and medical imaging.An evaluation of the manufacturing record could not be completed.The part number/lot number combination needed for device identification remains unknown.An evaluation of the device could not be completed.The device was not returned to endologix for evaluation because it remains implanted.A clinical evaluation of the adverse event/incident was completed.An examination of medical records and/or medical imaging received by endologix shows the reported type iiib endoleak (of the proximal extension) and secondary endovascular procedure are confirmed.This is consistent with the reported adverse event/incident.The clinical evaluation also shows reasonable evidence to suggest crown separation occurred that was not included in the event as reported.This finding was discovered during an examination of an undated ct (computed tomography) scan.Procedure-related harms, device, user, procedure, or anatomy relatedness of this event could not be determined with the medical records available for review.The final patient status was not reported.No additional investigation of this reported adverse event/incident is planned.However, should additional information relevant to the investigation outcome become available, a follow-up report will be submitted.Endologix will continue to monitor this and similar adverse events/incidents.Device iteration is unknown.Corrections: b5 describe event or problem.D2 common device name (primary).D4 lot expiration date (primary); remove data.G3 awareness date.H6 medical device problem codes; remove 3190.H6 investigation finding codes; remove 3233.H6 investigation conclusion codes; remove 11.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AFX
Type of Device
PROXIMAL EXTENSION
Manufacturer (Section D)
ENDOLOGIX
2 musick
irvine CA 92618
Manufacturer (Section G)
ENDOLOGIX
2 musick
,
irvine CA 92618
Manufacturer Contact
gary kirchgater
2 musick
,
irvine, CA 92618
8009832284
MDR Report Key12845173
MDR Text Key281028348
Report Number2031527-2021-00469
Device Sequence Number1
Product Code MIH
Combination Product (y/n)N
Reporter Country CodeIT
PMA/PMN Number
P040002
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Remedial Action Other
Type of Report Initial,Followup
Report Date 11/03/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date11/19/2021
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 11/03/2021
Initial Date FDA Received11/19/2021
Supplement Dates Manufacturer Received12/12/2021
Supplement Dates FDA Received01/13/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-